Verastem (VSTM) Non-Current Assets (2011 - 2026)

Verastem's (VSTM) quarterly Non-Current Assets came in at $24.9 million in Q1 2026, up 255.82% year-on-year from $7.0 million in Q1 2025, and up 8.14% quarter-over-quarter from $23.0 million in Q4 2025.

Verastem (VSTM) Non-Current Assets (2011 - 2026) Analysis & Trends

Verastem's Non-Current Assets history runs 16 years deep, the most recent figure standing at $24.9 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 255.82% year-over-year to $24.9 million in Q1 2026; TTM through Mar 2026 was $92.7 million, a 265.14% increase from a year earlier, with the FY2025 full-year figure at $23.0 million, up 250.14% from the prior year.
  • Non-Current Assets improved to $24.9 million in Q1 2026 per VSTM's latest filing, from $23.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $24.9 million in Q1 2026 and bottomed at $1.7 million in Q3 2023.
  • The 5-year median for Non-Current Assets is $5.9 million (2024), against an average of $8.5 million.
  • Across the five-year window, Non-Current Assets sank 72.25% in 2022 and surged 298.81% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $2.2 million in 2022, then surged by 176.88% to $6.0 million in 2023, then grew by 8.96% to $6.6 million in 2024, then surged by 250.14% to $23.0 million in 2025, then rose by 8.14% to $24.9 million in 2026.
  • Per Business Quant, the three latest VSTM Non-Current Assets figures stand at $24.9 million (Q1 2026), $23.0 million (Q4 2025), and $22.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn 24.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.90 Mn
Dec 31, 2025 23.03 Mn
Sep 30, 2025 22.80 Mn
Jun 30, 2025 21.99 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 6.58 Mn
Sep 30, 2024 5.72 Mn
Jun 30, 2024 6.10 Mn
Mar 31, 2024 5.87 Mn
Dec 31, 2023 6.04 Mn
Sep 30, 2023 1.67 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 1.98 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 2.34 Mn
Jun 30, 2022 2.53 Mn
Mar 31, 2022 2.71 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 3.12 Mn
Jun 30, 2021 9.13 Mn